Galantamine Hydrobromide Orally Disintegrating Tablets Market Report – Research, Industry Analysis Reports and Market Demands

Global Galantamine Hydrobromide Orally Disintegrating Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 12mg (Calculated as C₁₇H₂₁NO₃)
- 1.3.3 4mg (Calculated as C₁₇H₂₁NO₃)
- 1.3.4 8mg (Calculated as C₁₇H₂₁NO₃)
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
1.5 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size & Forecast
- 1.5.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity (2021-2032)
- 1.5.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Galantamine Hydrobromide Orally Disintegrating Tablets by Manufacturer

3.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Manufacturer (2021-2026)
3.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Manufacturer (2021-2026)
3.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Galantamine Hydrobromide Orally Disintegrating Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Galantamine Hydrobromide Orally Disintegrating Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Galantamine Hydrobromide Orally Disintegrating Tablets Manufacturer Market Share in 2025
3.5 Galantamine Hydrobromide Orally Disintegrating Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Galantamine Hydrobromide Orally Disintegrating Tablets Market: Region Footprint
- 3.5.2 Galantamine Hydrobromide Orally Disintegrating Tablets Market: Company Product Type Footprint
- 3.5.3 Galantamine Hydrobromide Orally Disintegrating Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region
- 4.1.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price by Region (2021-2032)
4.2 North America Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021-2032)
4.3 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021-2032)
4.4 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021-2032)
4.5 South America Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021-2032)
4.6 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
5.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Type (2021-2032)
5.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
6.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Application (2021-2032)
6.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price by Application (2021-2032)

7 North America

7.1 North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
7.2 North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
7.3 North America Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country
- 7.3.1 North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
8.2 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
8.3 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country
- 8.3.1 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region
- 9.3.1 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
10.2 South America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
10.3 South America Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country
- 10.3.1 South America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country
- 11.3.1 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Galantamine Hydrobromide Orally Disintegrating Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Galantamine Hydrobromide Orally Disintegrating Tablets Market Drivers
12.2 Galantamine Hydrobromide Orally Disintegrating Tablets Market Restraints
12.3 Galantamine Hydrobromide Orally Disintegrating Tablets Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Galantamine Hydrobromide Orally Disintegrating Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Galantamine Hydrobromide Orally Disintegrating Tablets
13.3 Galantamine Hydrobromide Orally Disintegrating Tablets Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Galantamine Hydrobromide Orally Disintegrating Tablets Typical Distributors
14.3 Galantamine Hydrobromide Orally Disintegrating Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Galantamine Hydrobromide Orally Disintegrating Tablets market size was valued at US$ 13.84 million in 2025 and is forecast to a readjusted size of US$ 18.13 million by 2032 with a CAGR of 4.0% during review period.
Galantamine hydrobromide orally disintegrating tablets are a pharmaceutical preparation containing galantamine hydrobromide as an active ingredient, designed for the treatment of cognitive impairment diseases such as Alzheimer's disease. The drug inhibits the activity of acetylcholinesterase and increases the concentration of acetylcholine in the brain, thereby improving patients' cognitive function and daily living ability.
This report is a detailed and comprehensive analysis for global Galantamine Hydrobromide Orally Disintegrating Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Galantamine Hydrobromide Orally Disintegrating Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Galantamine Hydrobromide Orally Disintegrating Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Galantamine Hydrobromide Orally Disintegrating Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Galantamine Hydrobromide Orally Disintegrating Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Galantamine Hydrobromide Orally Disintegrating Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Galantamine Hydrobromide Orally Disintegrating Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Tianjin Meihua Biopharmaceutical Technology Co., Ltd., Hebei Aierhaitai Pharmaceutical Co., Ltd., Hefei Heyuan Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Galantamine Hydrobromide Orally Disintegrating Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
12mg (Calculated as C₁₇H₂₁NO₃)
4mg (Calculated as C₁₇H₂₁NO₃)
8mg (Calculated as C₁₇H₂₁NO₃)
Market segment by Application
Hospital
Clinic
Other
Major players covered
Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
Tianjin Meihua Biopharmaceutical Technology Co., Ltd.
Hebei Aierhaitai Pharmaceutical Co., Ltd.
Hefei Heyuan Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Galantamine Hydrobromide Orally Disintegrating Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, with price, sales quantity, revenue, and global market share of Galantamine Hydrobromide Orally Disintegrating Tablets from 2021 to 2026.
Chapter 3, the Galantamine Hydrobromide Orally Disintegrating Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Galantamine Hydrobromide Orally Disintegrating Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Galantamine Hydrobromide Orally Disintegrating Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Galantamine Hydrobromide Orally Disintegrating Tablets.
Chapter 14 and 15, to describe Galantamine Hydrobromide Orally Disintegrating Tablets sales channel, distributors, customers, research findings and conclusion.

Buy now